MicroStrategy is using convertible notes in a unique way to raise funds and buy more bitcoin. Sophisticated investors love these bonds because of the volatility allows for profitable trading ...

For many early-stage startups, choosing between a convertible note and a SAFE (Simple Agreement for Future Equity) is one of the first critical legal and strategic financing decisions. While both ...

MIDLAND, Texas--(BUSINESS WIRE)--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by ...

In the world of early stage investing, there exists a range of structures from the most founder friendly to the most investor friendly. The most investor-friendly structure involves some type of a ...

Opportunistic capital raise for general corporate purposes Either net proceeds from this offering or cash on hand to be used to purchase cash-settled capped calls to offset economic dilution up to a ...

ATLANTA--(BUSINESS WIRE)--Repay Holdings Corporation (NASDAQ: RPAY) (“REPAY” or the “Company”) today announced that it has priced an offering of $260.0 million aggregate principal amount of its ...

Duke Energy (DUK) announced the pricing of $1.3 billion in convertible senior notes due in 2029 through a private placement. This amount is higher than the previously stated $1 billion. The initial ...

CleanSpark upsized its convertible note offering to $1.15 billion at 0%. Approximately $460 million earmarked for share repurchases at $15.03 per share and the remainder allocated to power expansion, ...

GameStop is back in the news with another wave of shareholder dilution. The company announced plans to issue $1.3 billion of convertible senior notes with an additonal $200 million on the table as ...

The notes carry a 0% coupon, but can be converted into equity in the company if holders choose to redeem their notes for shares. Bitcoin treasury company Strategy announced on Friday that it will ...

MINNEAPOLIS, July 28, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today ...